Endoscopic heart bypass trial starts in the US:
This article was originally published in Clinica
Executive Summary
Intuitive Surgical has begun a multicentre clinical trial in the US to assess use of its robotic surgery system in closed-chest, totally endoscopic coronary artery bypass (TECAB) surgery. TECAB procedures performed using the da Vinci system require only three or four pencil-sized holes made between the ribs. Through these holes, two robotic "arms" and a camera system gain exposure to the heart, allowing the surgeon to perform surgery without opening the chest, says the Mountain View, California firm.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.